Early pathological findings of COVID-19 patients with ARDS, showed not only reduced counts of peripheral CD4+ and CD8+ T cells, but that remaining T cells were found in a hyperactivated state, with high proportions of HLA-DR and CD38 double-positive fractions (80). The gene discussed is CD8A; the disease is COVID-19.